Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-16T21:06:07.329Z Has data issue: false hasContentIssue false

Gene expression profiling of suicide completers

Published online by Cambridge University Press:  16 April 2020

L.M. Fiori
Affiliation:
McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Montreal, Quebec, Canada
G. Turecki*
Affiliation:
McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Montreal, Quebec, Canada
*
*Corresponding author. Douglas Mental Health University Institute, 6875 LaSalle Boulevard, Verdun, Quebec, Canada, H4H 1R3. Tel.: +1 514 761 6131x2369; fax: +1 514 762 3023. E-mail address: gustavo.turecki@mcgill.ca (G. Turecki).
Get access

Abstract

Despite strong evidence for a role of biological factors in the etiology and pathology of suicide, the study of traditional neurotransmitter systems has been able to explain only a small proportion of the neurobiology of what is now recognized as a complex genetic trait. The use of microarrays to simultaneously examine the expression levels of thousands of gene transcripts has vastly expanded our capacity to detect the involvement of additional genes and pathways in suicidality, and has opened many new avenues for the discovery of the biological underpinnings of suicide completion. This review examines microarray studies which have been used to identify genes displaying altered expression in suicide completers, and highlights some of the important methodological considerations and metabolic pathways which have emerged from these analyses.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.